Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2022

MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Move to Begin EV Battery Pack Production Featured in Recent Articles

Posted on April 22, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in recent articles published by TheDetroitBureau.com and Auto Futures that discussed the company’s plans to begin EV battery pack production out of its high voltage battery R&D facility … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) to Release Q4 2021, Year-End Financial and Corporate Report

Posted on April 22, 2022 by MissionIR

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, released its fourth quarter 2021 and year-end financial results along with a corporate update on Thursday, April 21, 2022. In conjunction with that, the company has scheduled a … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

Knightscope, Inc. (NASDAQ: KSCP) Leveraging Robot Roadshow to Promote its ASRs and KSOC to Potential Clients

Posted on April 22, 2022 by MissionIR

Knightscope’s Robot Roadshow has so far made 38 landings across 12 states in the US The plan is to continue the roadshow to as many cities across the country as possible Upcoming landings include Columbus and Washington DC in time … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures First-Ever Patent for DehydraTECH to Deliver Antiviral Drugs

Posted on April 21, 2022 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of its first-ever patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs. According to the update, Lexaria has received … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Adds to Growing List of Fortune 500 Clients

Posted on April 21, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced its addition of a centuries-old consumer foods manufacturer to its growing list of Fortune 500 clients. The announcement reads, “Knightscope’s K5 autonomous … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Work with Clinilabs on Phase 1/2a Trial Focused on CYB003 for MDD Treatment

Posted on April 21, 2022 by MissionIR

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has partnered with Clinilabs Drug Development Corporation to work on its upcoming phase 1/2a clinical trial of CYB003. Clinilabs is a global, full-service contract research organization … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Conduct Solid-State Polymer Battery Cell Testing with Leading Independent Facility

Posted on April 21, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced solid-state polymer battery testing with the Battery Innovation Center (“BIC”) in Indiana. Started in 2013, BIC’s mission is focused on promoting the rapid development, testing, commercialization, and advanced … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio

Posted on April 21, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is launching business-to-business sales of its rare cannabinoid cannabidivarin (“CBDV”). Through subsidiary BayMedica LLC, InMed will offer its product to wholesalers, suppliers and end-product … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) to Host Update Call, Release Q4 and Year-End 2021 Financial Report

Posted on April 21, 2022 by MissionIR

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, announced that it will release its financial results for the fourth quarter 2021 and year-end 2021 period today after market close. In addition, the company will host a … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

From Shell (NYSE: SHEL) to EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Renewable Natural Gas is a Market Investors Should be Watching

Posted on April 21, 2022 by MissionIR

There is an accelerating trend to utilize Renewable Natural Gas (“RNG”), including investments by companies big and small to produce RNG from waste to greatly reduce carbon emissions Shell has its first U.S. facility in Oregon and agreements to provide … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment